Third-generation CD19.CAR-T cell-containing combination therapy in Scl70+ systemic sclerosis
Open Access
- 22 December 2023
- journal article
- letter
- Published by Elsevier in Annals of the Rheumatic Diseases
- Vol. 83 (4) , 543-546
Abstract
No abstract availableKeywords
Funding Information
- Deutsche Forschungsgemeinschaft (TR 466-4-1)
- Deutsche Gesellschaft für Innere Medizin e.V. (none)
This publication has 16 references indexed in Scilit:
- Interstitial lung diseasesThe Lancet, 2022
- [68 Ga]Ga-FAPI-46 PET for non-invasive detection of pulmonary fibrosis disease activityEuropean Journal of Nuclear Medicine and Molecular Imaging, 2022
- Idiopathic Pulmonary Fibrosis (an Update) and Progressive Pulmonary Fibrosis in Adults: An Official ATS/ERS/JRS/ALAT Clinical Practice GuidelineAmerican Journal of Respiratory and Critical Care Medicine, 2022
- Obinutuzumab in connective tissue diseases after former rituximab-non-response: a case seriesAnnals of the Rheumatic Diseases, 2022
- Effect of JAK Inhibition on the Induction of Proinflammatory HLA–DR+CD90+ Rheumatoid Arthritis Synovial Fibroblasts by Interferon‐γArthritis & Rheumatology, 2021
- Fibroblast Activation Protein–Specific PET/CT Imaging in Fibrotic Interstitial Lung Diseases and Lung Cancer: A Translational Exploratory StudyJournal of Nuclear Medicine, 2021
- CXCL4 assembles DNA into liquid crystalline complexes to amplify TLR9-mediated interferon-α production in systemic sclerosisNature Communications, 2019
- Visual vs Fully Automatic Histogram-Based Assessment of Idiopathic Pulmonary Fibrosis (IPF) Progression Using Sequential Multidetector Computed Tomography (MDCT)PLOS ONE, 2015
- Fludarabine-Related Pulmonary ToxicityChest, 2002
- Serum immune complexes in systemic sclerosis: relationship with precipitating nuclear antibodies.Annals of the Rheumatic Diseases, 1985